Myriad Genetics (MYGN) Share-based Compensation Growth (3y) (2012 - 2026)
Myriad Genetics (MYGN) Share-based Compensation Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.99 Bn | 209.92 Bn | 8.34 Bn | 3.48% |
| 2 | Danaher | 140.41 Bn | 136.06 Bn | 3.61 Bn | -1.05% |
| 3 | Idexx Laboratories | 46.27 Bn | 46.08 Bn | 779.09 Mn | 1.55% |
| 4 | Agilent Technologies | 39.81 Bn | 38.00 Bn | 990.00 Mn | 25.99% |
| 5 | Iqvia Holdings | 39.53 Bn | 37.45 Bn | 1.44 Bn | 23.86% |
| 6 | Natera | 38.83 Bn | 37.73 Bn | 696.04 Mn | -73.26% |
| 7 | Illumina | 30.03 Bn | 28.86 Bn | 770.00 Mn | -11.69% |
| 8 | Mettler Toledo International | 28.67 Bn | 28.62 Bn | 650.22 Mn | 8.59% |
| 9 | Quest Diagnostics | 26.16 Bn | 25.54 Bn | 1.03 Bn | -20.63% |
| 10 | Myriad Genetics | 294.69 Mn | 170.29 Mn | 137.60 Mn | -4.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.66% |
| Dec 31, 2025 | 23.13% |
| Sep 30, 2025 | 9.08% |
| Jun 30, 2025 | 0.95% |
| Mar 31, 2025 | -2.02% |
| Dec 31, 2024 | 62.52% |
| Sep 30, 2024 | -23.13% |
| Jun 30, 2024 | 425.36% |
| Mar 31, 2024 | 159.13% |
| Dec 31, 2023 | -51.00% |
| Sep 30, 2023 | 11.36% |
| Jun 30, 2023 | 6.01% |
| Mar 31, 2023 | 321.72% |
| Dec 31, 2022 | -5.90% |
| Sep 30, 2022 | 2.22% |
| Jun 30, 2022 | 5.73% |
| Mar 31, 2022 | 74.52% |
| Dec 31, 2021 | -102.53% |
| Sep 30, 2021 | 143.11% |
| Jun 30, 2021 | -81.91% |